FDA Approved: OVIDREL — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OVIDREL (chorionic gonadotropin alfa) filed by EMD Serono, Inc., resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Ovidrel (Choriogonadotropin alfa)

Snippet

SUPPL AP for OVIDREL (CHORIOGONADOTROPIN ALFA)